loading...| Preferred Name |
lopinavir |
|
| Synonyms |
LPV (2S)-N-[(2S,4S,5S)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide |
|
| Definitions |
This is any condition in which the main influencing factor is lopinavir, an HIV protease inhibitor used in a fixed-dose combination with ritonavir. Lopinavir is also a cytochrome P-450 inhibitor. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0001172 |
|
| created_by |
slaulederkind |
|
| creation_date |
2023-12-08T16:01:36Z |
|
| database_cross_reference |
CID:92727 CHEBI:31781 |
|
| definition |
This is any condition in which the main influencing factor is lopinavir, an HIV protease inhibitor used in a fixed-dose combination with ritonavir. Lopinavir is also a cytochrome P-450 inhibitor. |
|
| has_exact_synonym |
LPV (2S)-N-[(2S,4S,5S)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0001172 |
|
| label |
lopinavir |
|
| notation |
XCO:0001172 |
|
| prefLabel |
lopinavir |
|
| treeView | ||
| subClassOf |